Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044850070> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W2044850070 endingPage "506" @default.
- W2044850070 startingPage "506" @default.
- W2044850070 abstract "BBC 2, 27 February at 9 pm Rating: ![Graphic][1]</img>![Graphic][2]</img> The notion of gene therapy—the “overpowering” of a defective gene with a correct copy—is beguilingly simple. For patients with life threatening genetic diseases and for doctors frustrated by their inability to intervene and change the course of the disorder, attacking the underlying biology and dealing with the condition at source is an attractive and potentially effective option. For scientists, the opportunity to work in frontier biology with the possibility of creating platform technologies that may cure disease has inspired some of the brightest and best minds. But is gene therapy, as this Horizon programme claimed, the “miracle that crashed into tragedy”? The programme told the story of Jesse Gelsinger, a young man with OTC (ornithine transcarbamylase) deficiency. He entered a gene therapy trial in the … [1]: /embed/inline-graphic-1.gif [2]: /embed/inline-graphic-2.gif" @default.
- W2044850070 created "2016-06-24" @default.
- W2044850070 creator A5000357593 @default.
- W2044850070 date "2003-03-01" @default.
- W2044850070 modified "2023-10-14" @default.
- W2044850070 title "TV: Horizon: Trial and Error" @default.
- W2044850070 doi "https://doi.org/10.1136/bmj.326.7387.506" @default.
- W2044850070 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1125395" @default.
- W2044850070 hasPublicationYear "2003" @default.
- W2044850070 type Work @default.
- W2044850070 sameAs 2044850070 @default.
- W2044850070 citedByCount "1" @default.
- W2044850070 crossrefType "journal-article" @default.
- W2044850070 hasAuthorship W2044850070A5000357593 @default.
- W2044850070 hasConcept C118552586 @default.
- W2044850070 hasConcept C138885662 @default.
- W2044850070 hasConcept C27206212 @default.
- W2044850070 hasConcept C2778875440 @default.
- W2044850070 hasConcept C2780027720 @default.
- W2044850070 hasConcept C41008148 @default.
- W2044850070 hasConcept C71924100 @default.
- W2044850070 hasConceptScore W2044850070C118552586 @default.
- W2044850070 hasConceptScore W2044850070C138885662 @default.
- W2044850070 hasConceptScore W2044850070C27206212 @default.
- W2044850070 hasConceptScore W2044850070C2778875440 @default.
- W2044850070 hasConceptScore W2044850070C2780027720 @default.
- W2044850070 hasConceptScore W2044850070C41008148 @default.
- W2044850070 hasConceptScore W2044850070C71924100 @default.
- W2044850070 hasIssue "7387" @default.
- W2044850070 hasLocation W20448500701 @default.
- W2044850070 hasOpenAccess W2044850070 @default.
- W2044850070 hasPrimaryLocation W20448500701 @default.
- W2044850070 hasRelatedWork W2014799010 @default.
- W2044850070 hasRelatedWork W2479716286 @default.
- W2044850070 hasRelatedWork W2748952813 @default.
- W2044850070 hasRelatedWork W2899084033 @default.
- W2044850070 hasRelatedWork W2911919299 @default.
- W2044850070 hasRelatedWork W2937516474 @default.
- W2044850070 hasRelatedWork W2952340191 @default.
- W2044850070 hasRelatedWork W3008640730 @default.
- W2044850070 hasRelatedWork W3132951149 @default.
- W2044850070 hasRelatedWork W3152671491 @default.
- W2044850070 hasVolume "326" @default.
- W2044850070 isParatext "false" @default.
- W2044850070 isRetracted "false" @default.
- W2044850070 magId "2044850070" @default.
- W2044850070 workType "article" @default.
!["BBC 2, 27 February at 9 pm Rating: ![Graphic][1]</img>![Graphic][2]</img> The notion of gene therapy—the “overpowering” of a defective gene with a correct copy—is beguilingly simple. For patients with life threatening genetic diseases and for doctors frustrated by their inability to intervene and change the course of the disorder, attacking the underlying biology and dealing with the condition at source is an attractive and potentially effective option. For scientists, the opportunity to work in frontier biology with the possibility of creating platform technologies that may cure disease has inspired some of the brightest and best minds. But is gene therapy, as this Horizon programme claimed, the “miracle that crashed into tragedy”? The programme told the story of Jesse Gelsinger, a young man with OTC (ornithine transcarbamylase) deficiency. He entered a gene therapy trial in the … [1]: /embed/inline-graphic-1.gif [2]: /embed/inline-graphic-2.gif"](?object=%22BBC%202%2C%2027%20February%20at%209%20pm%20Rating%3A%20!%5BGraphic%5D%5B1%5D%3C%2Fimg%3E!%5BGraphic%5D%5B2%5D%3C%2Fimg%3E%20The%20notion%20of%20gene%20therapy%E2%80%94the%20%E2%80%9Coverpowering%E2%80%9D%20of%20a%20defective%20gene%20with%20a%20correct%20copy%E2%80%94is%20beguilingly%20simple.%20For%20patients%20with%20life%20threatening%20genetic%20diseases%20and%20for%20doctors%20frustrated%20by%20their%20inability%20to%20intervene%20and%20change%20the%20course%20of%20the%20disorder%2C%20attacking%20the%20underlying%20biology%20and%20dealing%20with%20the%20condition%20at%20source%20is%20an%20attractive%20and%20potentially%20effective%20option.%20For%20scientists%2C%20the%20opportunity%20to%20work%20in%20frontier%20biology%20with%20the%20possibility%20of%20creating%20platform%20technologies%20that%20may%20cure%20disease%20has%20inspired%20some%20of%20the%20brightest%20and%20best%20minds.%20But%20is%20gene%20therapy%2C%20as%20this%20Horizon%20programme%20claimed%2C%20the%20%E2%80%9Cmiracle%20that%20crashed%20into%20tragedy%E2%80%9D%3F%20The%20programme%20told%20the%20story%20of%20Jesse%20Gelsinger%2C%20a%20young%20man%20with%20OTC%20(ornithine%20transcarbamylase)%20deficiency.%20He%20entered%20a%20gene%20therapy%20trial%20in%20the%20%E2%80%A6%20%5B1%5D%3A%20%2Fembed%2Finline-graphic-1.gif%20%5B2%5D%3A%20%2Fembed%2Finline-graphic-2.gif%22){kind=link}